Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Cancer Cell

Volumn 4, Issue 6, 2003, Pages 437-450

  Hingorani, Sunil R ^a   Petricoin III, Emanuel F ^b   Maitra, Anirban ^c   Rajapakse, Vinodh ^d   King, Catrina ^a   Jacobetz, Michael A ^a   Ross, Sally ^d   Conrads, Thomas P ^e   Veenstra, Timothy D ^e   Hitt, Ben A ^f   Kawaguchi, Yoshiya ^g   Johann, Don ^d   Liotta, Lance A ^d   Crawford, Howard C ^h   Putt, Mary E ⁱ   Jacks, Tyler ^j   Wright, Christopher V E ^g   Hruban, Ralph H ^c   Lowy, Andrew M ^k   Tuveson, David A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Correlogic Systems Inc ^*  (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h STONY BROOK UNIVERSITY   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^k UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; GENE MUTATION; GENE TARGETING; METASTASIS; MOUSE; NONHUMAN; ONCOGENE K RAS; ONCOGENE RAS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALIA;

EID: 9144266295     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00309-X     Document Type: Article

References (60)

1. Adam B.L., Qu Y., Davis J.W., Ward M.D., Clements M.A., Cazares L.H., Semmes O.J., Schellhammer P.F., Yasui Y., Feng Z., Wright G.L. Jr. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62:2002;3609-3614.
2. Aguirre A.J., Bardeesy N., Sinha M., Lopez L., Tuveson D.A., Horner J., Redston M.S., DePinho R.A. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma in the mouse. Genes Dev. in press:2003.
3. Allison D.C., Piantadosi S., Hruban R.H., Dooley W.C., Fishman E.K., Yeo C.J., Lillemoe K.D., Pitt H.A., Lin P., Cameron J.L. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J. Surg. Oncol. 67:1998;151-159.
4. Anderson K.E., Johnson T.W., Lazovich D., Folsom A.R. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J. Natl. Cancer Inst. 94:2002;1168-1171.
5. Apelqvist A., Li H., Sommer L., Beatus P., Anderson D.J., Honjo T., Hrabe de Angelis M., Lendahl U., Edlund H. Notch signalling controls pancreatic cell differentiation. Nature. 400:1999;877-881.
6. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling. Cell fate control and signal integration in development Science. 284:1999;770-776.
7. Brembeck F.H., Schreiber F.S., Deramaudt T.B., Craig L., Rhoades B., Swain G., Grippo P., Stoffers D.A., Silberg D.G., Rustgi A.K. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res. 63:2003;2005-2009.
8. Brinckerhoff C.E., Matrisian L.M. Matrix metalloproteinases. A tail of a frog that became a prince Nat. Rev. Mol. Cell Biol. 3:2002;207-214.
9. Coussens L.M., Fingleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer. trials and tribulations Science. 295:2002;2387-2392.
10. Crawford H.C., Scoggins C.R., Washington M.K., Matrisian L.M., Leach S.D. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J. Clin. Invest. 109:2002;1437-1444.
11. Cubilla A.L., Fitzgerald P.J. Morphological patterns of primary nonendocrine human pancreas carcinoma. Cancer Res. 35:1975;2234-2248.
12. Cubilla A.L., Fitzgerald P.J. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res. 36:1976;2690-2698.
13. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
14. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
15. Fortini M.E. Gamma-secretase-mediated proteolysis in cell-surface- receptor signalling. Nat. Rev. Mol. Cell Biol. 3:2002;673-684.
16. Grippo P.J., Nowlin P.S., Demeure M.J., Longnecker D.S., Sandgren E.P. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res. 63:2003;2016-2019.
17. Guerra C., Mijimolle N., Dhawahir A., Dubus P., Barradas M., Serrano M., Campuzano V., Barbacid M. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell. 4:2003;111-120.
18. Hingorani S.R., Tuveson D.A. In search of an early warning system for pancreatic cancer. Cancer Biol. Ther. 2:2003;84-86.
19. Hruban R.H., Goggins M., Parsons J., Kern S.E. Progression model for pancreatic cancer. Clin. Cancer Res. 6:2000;2969-2972. a.
20. Hruban R.H., Wilentz R.E., Kern S.E. Genetic progression in the pancreatic ducts. Am. J. Pathol. 156:2000;1821-1825. b.
21. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1994;1-7.
22. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., Jacks T., Tuveson D.A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15:2001;3243-3248.
23. Jaffee E.M., Hruban R.H., Canto M., Kern S.E. Focus on pancreas cancer. Cancer Cell. 2:2002;25-28.
24. Jankowsky J.L., Slunt H.H., Ratovitski T., Jenkins N.A., Copeland N.G., Borchelt D.R. Co-expression of multiple transgenes in mouse CNS. A comparison of strategies Biomol. Eng. 17:2001;157-165.
25. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics, 2003. CA Cancer J. Clin. 53:2003;5-26.
26. Jensen J., Pedersen E.E., Galante P., Hald J., Heller R.S., Ishibashi M., Kageyama R., Guillemot F., Serup P., Madsen O.D. Control of endodermal endocrine development by Hes-1. Nat. Genet. 24:2000;36-44.
27. Johnson L., Mercer K., Greenbaum D., Bronson R.T., Crowley D., Tuveson D.A., Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 410:2001;1111-1116.
28. Josien H. Recent advances in the development of gamma-secretase inhibitors. Curr. Opin. Drug Discov. Dev. 5:2002;513-525.
29. Kawaguchi Y., Cooper B., Gannon M., Ray M., MacDonald R.J., Wright C.V. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat. Genet. 32:2002;128-134.
30. Kern S., Hruban R., Hollingsworth M.A., Brand R., Adrian T.E., Jaffee E., Tempero M.A. A white paper. The product of a pancreas cancer think tank Cancer Res. 61:2001;4923-4932.
31. Kim S.K., MacDonald R.J. Signaling and transcriptional control of pancreatic organogenesis. Curr. Opin. Genet. Dev. 12:2002;540-547.
32. Klimstra D.S., Longnecker D.S. K-ras mutations in pancreatic ductal proliferative lesions. Am. J. Pathol. 145:1994;1547-1550.
33. Krapp A., Knofler M., Ledermann B., Burki K., Berney C., Zoerkler N., Hagenbuchle O., Wellauer P.K. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 12:1998;3752-3763.
34. Land H., Parada L.F., Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 304:1983;596-602.
35. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48:2002;1296-1304.
36. Liotta L.A., Ferrari M., Petricoin E. Clinical proteomics. Written in blood Nature. 425:2003;905.
37. Lowenfels A.B., Maisonneuve P., Cavallini G., Ammann R.W., Lankisch P.G., Andersen J.R., Dimagno E.P., Andren-Sandberg A., Domellof L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N. Engl. J. Med. 328:1993;1433-1437.
38. Maitra A., Ashfaq R., Gunn C.R., Rahman A., Yeo C.J., Sohn T.A., Cameron J.L., Hruban R.H., Wilentz R.E. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia. an immunohistochemical analysis with automated cellular imaging Am. J. Clin. Pathol. 118:2002;194-201.
39. Miyamoto Y., Maitra A., Ghosh B., Zechner U., Argani P., Iacobuzio-Donahue C.A., Sriuranpong V., Iso T., Meszoely I.M., Wolfe M.S.et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell. 3:2003;565-576.
40. Offield M.F., Jetton T.L., Labosky P.A., Ray M., Stein R.W., Magnuson M.A., Hogan B.L., Wright C.V. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development. 122:1996;983-995.
41. Petricoin E.F. 3rd, Ornstein D.K., Paweletz C.P., Ardekani A., Hackett P.S., Hitt B.A., Velassco A., Trucco C., Wiegand L., Wood K.et al. Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. 94:2002;1576-1578. a.
42. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., Mills G.B., Simone C., Fishman D.A., Kohn E.C., Liotta L.A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 359:2002;572-577. b.
43. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature. 414:2001;105-111.
44. Rosty C., Goggins M. Early detection of pancreatic carcinoma. Hematol. Oncol. Clin. North Am. 16:2002;37-52.
45. Rudolph-Owen L.A., Chan R., Muller W.J., Matrisian L.M. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res. 58:1998;5500-5506.
46. Ruley H.E. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature. 304:1983;602-606.
47. Sandgren E.P., Luetteke N.C., Palmiter R.D., Brinster R.L., Lee D.C. Overexpression of TGF alpha in transgenic mice. induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast Cell. 61:1990;1121-1135.
48. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:1996;27-37.
49. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
50. Shields J.M., Pruitt K., McFall A., Shaub A., Der C.J. Understanding Ras. 'it ain't over 'til it's over' Trends Cell Biol. 10:2000;147-154.
51. Sirard C., de la Pompa J.L., Elia A., Itie A., Mirtsos C., Cheung A., Hahn S., Wakeham A., Schwartz L., Kern S.E.et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12:1998;107-119.
52. Suzuki A., de la Pompa J.L., Hakem R., Elia A., Yoshida R., Mo R., Nishina H., Chuang T., Wakeham A., Itie A.et al. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11:1997;1242-1252.
53. Tucker O.N., Dannenberg A.J., Yang E.K., Zhang F., Teng L., Daly J.M., Soslow R.A., Masferrer J.L., Woerner B.M., Koki A.T., Fahey T.J. 3rd. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 59:1999;987-990.
54. Urgell E., Puig P., Boadas J., Capella G., Queralto J.M., Boluda R., Antonijuan A., Farre A., Lluis F., Gonzalez-Sastre F., Mora J. Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer. Eur. J. Cancer. 36:2000;2069-2075.
55. Wagner M., Luhrs H., Kloppel G., Adler G., Schmid R.M. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology. 115:1998;1254-1262.
56. Wagner M., Greten F.R., Weber C.K., Koschnick S., Mattfeldt T., Deppert W., Kern H., Adler G., Schmid R.M. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev. 15:2001;286-293.
57. Warshaw A.L., Fernandez-del Castillo C. Pancreatic carcinoma. N. Engl. J. Med. 326:1992;455-465.
58. Wilson C.L., Heppner K.J., Labosky P.A., Hogan B.L., Matrisian L.M. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA. 94:1997;1402-1407.
59. Yeo C.J., Cameron J.L., Lillemoe K.D., Sohn T.A., Campbell K.A., Sauter P.K., Coleman J., Abrams R.A., Hruban R.H. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2. Randomized controlled trial evaluating survival, morbidity, and mortality Ann. Surg. 236:2002;355-366. a.
60. Yeo T.P., Hruban R.H., Leach S.D., Wilentz R.E., Sohn T.A., Kern S.E., Iacobuzio-Donahue C.A., Maitra A., Goggins M., Canto M.I.et al. Pancreatic cancer. Curr. Probl. Cancer. 26:2002;176-275. b.